Evaluation of the effects of lemongrass on clinical and electrodiagnostic symptoms of type 2 diabetes
Phase 3
Recruiting
- Conditions
- Type 2 diabetes.Type 1 diabetes mellitus
- Registration Number
- IRCT20200612047739N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Type 2 diabetes
Age over 18 years
Body mass index 18.5–30 kg / m
Willing to participate in the study
Exclusion Criteria
Type 1 diabetes
Pregnancy or other specific types of diabetes
Insulin therapy over the past three months
Having serious gastrointestinal (GI) diseases including stomach ulcers and gastrointestinal bleeding
Having an autoimmune disease
Osteoarthritis
Chronic uremia
Use of drugs that affect the symptoms of neuropathy such as antidepressants and anticonvulsants
Allergy to Lemongrass
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical signs of neuropathy. Timepoint: Beginning and end of three months of treatment. Method of measurement: Physical examination.;Electrodiagnostic findings. Timepoint: Beginning and end of three months of treatment. Method of measurement: An electromyographic device will be used for this purpose.;Laboratory findings including Fasting blood sugar and hemoglobin A1c. Timepoint: Beginning and end of three months of treatment. Method of measurement: Based on laboratory evaluation of patients.
- Secondary Outcome Measures
Name Time Method